Category: Resus & Crit Care

Tocilizumab

Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s

Hot on the heels of a terrific pun and blog post about the use of Tocilizumab, capturing all the intrigue, hope and caution with the potential use of this novel therapeutic agent for patients with severe

Ludwig's angina St Emlyn's

Ludwig’s Angina. St Emlyn’s

There’s two reasons why Ludwig’s angina sends a shiver down my spine but probably only one of them will apply to you. Back in 2003 when I was a third year medical student my consultant

October 2020

October 2020 round up podcast

October was a busy month with a strong theme of trauma and coagulopathy. Iain and Simon got together to podcast the highlights which you can listen to on the link below, or even better subscribe

JC: Early plasma use in traumatic brain injury. St Emlyn’s

There seems to be a lot of really interesting papers on Traumatic Brain Injury (TBI) this year. A welcome relief from COVID 19 perhaps but also a reminder that other pathologies exist and that TBI

JC: Finger on the Pulse?

If you’re an avid follower of FOAM, you’ll have seen many assertions that manual pulse checks by healthcare providers during cardiac arrest are pretty unreliable at best. The most commonly advocated alternatives are EtCO2 increase

JC: Should we rubber STAAMP prehospital TXA?

This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma, one argument has just been

JC: Blood Products in Trauma – What’s the Best (I)TACTIC?

Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed newer direct oral anticoagulant treatments

VTE and COVID-19: Would you like to know more?

That’s a leading question. Of course you would.  Who wouldn’t want to know more about a disease that has killed >1 million people to date, worldwide. Who wouldn’t want to know more about the thromboembolic risk associated

JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s

Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also be using it in mild/moderate

JC: TXA in severe head injury. St Emlyn’s

Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence was not entirely definitive, but

Translate »